As of 2025-12-16, the EV/EBITDA ratio of Angion Biomedica Corp (ANGN) is -0.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANGN's latest enterprise value is 8.43 mil USD. ANGN's TTM EBITDA according to its financial statements is -30.16 mil USD. Dividing these 2 quantities gives us the above ANGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 8.4x | 7.8x |
| Forward P/E multiples | 5.2x - 13.3x | 8.9x |
| Fair Price | (6.37) - (7.73) | (7.62) |
| Upside | -737.2% - -873.4% | -861.9% |
| Date | EV/EBITDA |